Injective Funding: $50M Raised, Series B (2022)

Injective has raised $50M in total funding. Latest round: Series B. Backed by Mark Cuban, Pantera Capital, BlockTower Capital.

Injective funding overview

Injective has raised $50M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series B announced in January 2022. The round record for Injective runs through 2022; nothing later has been disclosed. Investors on record include Mark Cuban, Pantera Capital, BlockTower Capital, Hashed Ventures, CMS Holdings, QCP Capital and 2 others. 8 distinct backers are named across the disclosed rounds.

Injective at a glance

Total raised
$50M
Latest round
Series B
Latest round date
January 2022
Notable investors
Mark Cuban, Pantera Capital, BlockTower Capital, Hashed Ventures, CMS Holdings, QCP Capital, Jump Crypto, BH Digital

Frequently asked about Injective funding

How much has Injective raised?
Injective has raised $50M in total disclosed funding across the rounds on record.
Who has invested in Injective?
Mark Cuban, Pantera Capital, BlockTower Capital, Hashed Ventures, CMS Holdings, QCP Capital are named among the investors backing Injective.
What was the latest Injective funding round?
The most recent disclosed round is a Series B, announced in January 2022.
Where is Injective based?
No headquarters location is disclosed for Injective.
When did Injective last raise?
The last disclosed Injective round closed in January 2022 at Series B.

We update the Injective record whenever a new round is filed or announced, so the totals above track the public record rather than estimates. Related companies and their backers are listed below.

Companies related to Injective (18)

Browse related funding lists (5)

Company funding database · Investor directory · Founder database · Mega-rounds 2026